U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07457944) titled 'Efficacy and Safety of Different Doses of Rituximab Therapy in Pemphigus Patients' on March 03.
Brief Summary: Investigating the clinical efficacy of different doses of rituximab in patients with pemphigus
Study Start Date: Jan. 01, 2019
Study Type: OBSERVATIONAL
Condition:
Pemphigus Disease
Rituximab (RTx)
Recruitment Status: COMPLETED
Sponsor: Ruijin Hospital
Published by HT Digital Content Services with permission from Health Daily Digest....